AMGEN INC

AMGEN INC

Displaying 10 out of 9 results

  1. A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris

    Sanofi, Regeneron lose US patent challenge to Amgen cholesterol drug

    A U.S. jury on Monday said patents owned by Amgen Inc on its cholesterol drug Rapatha are valid, rejecting a challenge by Regeneron ...
  2. FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in P

    Sanofi and Regeneron cut list price of cholesterol drug by 60 percent

    Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol ...
  3. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Amgen quarterly profit tops Street view, 2019 forecast falls short

    Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit as sales rose and tax expense fell, but competition for older medicines ...
  4. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Amgen's postmenopausal osteoporosis drug wins FDA panel backing

    An advisory panel to the U.S. Food and Drug Administration on Wednesday recommended Amgen Inc's osteoporosis treatment for postmenopausal women at ...
  5. An Amgen sign is seen at the company's office in South San Francisco

    US top court rejects Amgen over cholesterol medication patent fight

    The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals ...
  6. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Amgen cuts price of cholesterol drug Repatha by 60 percent

    Amgen Inc, looking to boost use of its potent cholesterol drug Repatha, has cut the medication's U.S. list price by 60 percent to US$5,850, the U.S.
  7. FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the

    Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

    Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, ...